<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A difference between <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> screening and screening for most other types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> is that various screening methods are available </plain></SENT>
<SENT sid="1" pm="."><plain>A choice between screening methods is common in the USA </plain></SENT>
<SENT sid="2" pm="."><plain>Most European programmes currently offer a single screening method, since it is recommended that only screening strategies with sufficient evidence for a reduction in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> mortality are introduced </plain></SENT>
<SENT sid="3" pm="."><plain>Faecal occult blood testing is widely accepted in Europe, and evidence on the effectiveness of flexible sigmoidoscopy is increasing </plain></SENT>
<SENT sid="4" pm="."><plain>The availability of multiple effective screening options warrants deliberation on whether individuals should be given a choice between strategies </plain></SENT>
<SENT sid="5" pm="."><plain>In this Personal View, we present arguments in favour and against offering a choice of screening strategies, together with the evidence substantiating these views </plain></SENT>
<SENT sid="6" pm="."><plain>We also focus on screening invitees' autonomy, which is a crucial parameter in the debate </plain></SENT>
</text></document>